Deferoxamine
Back to searchMolecule Structure
Scientific Name
Deferoxamine
Description of the Drug
Deferoxamine is a chelating agent used to treat iron or aluminum toxicity and some blood transfusion dependent anemias.
Source: DrugBank Online – DrugBank.com. Retrieved 2023-03-10 from
http://www.drugbank.ca/drugs/DB00746
http://www.drugbank.ca/drugs/DB00746
Brand Name(s)
Not Available
Company Owner(s)
Fresenius Kabi Usa Llc, West-Ward Pharmaceuticals International Ltd, Hospira Inc, Gland Pharma Ltd, Dr Reddys Laboratories Ltd, Novartis Pharmaceuticals Corp
Mechanism(s) Of Action
| Target Name | Target Type | Action Type | Target ChEMBL ID |
|---|---|---|---|
| Iron | METAL | CHELATING AGENT | CHEMBL2363058 |
Clinical Trial(s)
Unichem Links
| Atlas | deferoxamine | DFO | |||||
| SureChEMBL | SCHEMBL34571 | ||||||
| PharmGKB | PA164746490 | ||||||
| Human Metabolome Database | HMDB0014884 | ||||||
| DrugBank | DB00746 | ||||||
| PubChem: Thomson Pharma | 14788466 | ||||||
| PubChem | 2973 | ||||||
| Mcule | MCULE-3095507442 | ||||||
| NMRShiftDB | 70000541 | ||||||
| LINCS | LSM-6541 | ||||||
| Nikkaji | J10.199K | ||||||
| PDBe | KTY | ||||||
| BindingDB | 47715 | ||||||
| EPA CompTox Dashboard | DTXSID7022887 | ||||||
| LipidMaps | LMFA08020169 | ||||||
| DrugCentral | 792 | ||||||
| Metabolights | MTBLC4356 | ||||||
| Brenda | 4808 | 105891 | 49980 | 74729 | 105890 | 23293 | 217361 |
| ChemicalBook | CB8506290 | ||||||
| rxnorm | DESFERAL | DEFEROXAMINE MESYLATE | DEFEROXAMINE | ||||
| PubChem: Drugs of the Future | 12014086 | ||||||
| ChEBI | 4356 | ||||||
| ZINC | ZINC000003830635 |
